Your browser doesn't support javascript.
loading
A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2.
Yang, Shouhui; He, Peijun; Wang, Jian; Schetter, Aaron; Tang, Wei; Funamizu, Naotake; Yanaga, Katsuhiko; Uwagawa, Tadashi; Satoskar, Abhay R; Gaedcke, Jochen; Bernhardt, Markus; Ghadimi, B Michael; Gaida, Matthias M; Bergmann, Frank; Werner, Jens; Ried, Thomas; Hanna, Nader; Alexander, H Richard; Hussain, S Perwez.
Affiliation
  • Yang S; Pancreatic Cancer Unit, National Cancer Institute, Bethesda, Maryland. Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • He P; Pancreatic Cancer Unit, National Cancer Institute, Bethesda, Maryland. Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Wang J; Pancreatic Cancer Unit, National Cancer Institute, Bethesda, Maryland. Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Schetter A; Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Tang W; Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Funamizu N; Department of Surgery, Jikei University School of Medicine, Tokyo, Japan.
  • Yanaga K; Department of Surgery, Jikei University School of Medicine, Tokyo, Japan.
  • Uwagawa T; Department of Surgery, Jikei University School of Medicine, Tokyo, Japan.
  • Satoskar AR; Department Pathology and Microbiology, Ohio State University, Columbus, Ohio.
  • Gaedcke J; Department of General, Visceral and Pediatric Surgery, University Medicine, Göttingen, Germany.
  • Bernhardt M; Department of General, Visceral and Pediatric Surgery, University Medicine, Göttingen, Germany.
  • Ghadimi BM; Department of General, Visceral and Pediatric Surgery, University Medicine, Göttingen, Germany.
  • Gaida MM; Institute of Pathology, University of Heidelberg, Heidelberg, Germany.
  • Bergmann F; Institute of Pathology, University of Heidelberg, Heidelberg, Germany.
  • Werner J; Department of Surgery, Ludwig-Maximillians University, Munich, Germany.
  • Ried T; Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Hanna N; Division of Surgical Oncology, University of Maryland School of Medicine, Baltimore, Maryland.
  • Alexander HR; Division of Surgical Oncology, University of Maryland School of Medicine, Baltimore, Maryland.
  • Hussain SP; Pancreatic Cancer Unit, National Cancer Institute, Bethesda, Maryland. Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland. hussainp@mail.nih.gov.
Cancer Res ; 76(13): 3838-50, 2016 07 01.
Article de En | MEDLINE | ID: mdl-27197190
Sujet(s)
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du pancréas / Régulation de l'expression des gènes tumoraux / Facteurs inhibiteurs de la migration des macrophages / Récepteurs des minéralocorticoïdes / Intramolecular oxidoreductases / Carcinome du canal pancréatique / MicroARN Type d'étude: Prognostic_studies Limites: Animals / Humans Langue: En Journal: Cancer Res Année: 2016 Type de document: Article Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du pancréas / Régulation de l'expression des gènes tumoraux / Facteurs inhibiteurs de la migration des macrophages / Récepteurs des minéralocorticoïdes / Intramolecular oxidoreductases / Carcinome du canal pancréatique / MicroARN Type d'étude: Prognostic_studies Limites: Animals / Humans Langue: En Journal: Cancer Res Année: 2016 Type de document: Article Pays de publication: États-Unis d'Amérique